Drug Database
Back to search

Netherlands· NL-56a0928bda9e

Scopoderm 1 mg/72 uur, pleister voor transdermaal gebruik

A scopolamine product containing hyoscine, registered in Netherlands by Baxter B.V.. The same ATC class is registered in 6 of our 19 countries.

ATC A04AD01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedScopoderm 1 mg/72 uur, pleister voor …ATCA04AD01REGISTER NO.NL-56a0928bda9ePACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about hyoscineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Scopolamine is registered in 6 of 19 countries.

Countries holding a registration under ATC A04AD01 (scopolamine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 3 of them publish a price we can compare per daily dose
Search scopolamine products by name

Scopolamine · ATC A04AD01

6 / 19 countries

  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
HYOSCINE
Manufacturer
Baxter B.V.
Country
Netherlands (NL)
ATC code
A04AD01
ATC class
Scopolamine
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    09709

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

335 interactions on record for scopolamine.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check scopolamine against other medicinesHow interaction checks work

Scopolamine · interactions on record

335 records

  • 7 severe
  • 197 moderate
  • 17 minor
  • 114 info

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • DextropropoxypheneN02AC04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Scopolamine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All scopolamine products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Belgium · Scopolamine Hbr Sterop
  • Germany · Boro-Scopol N, Scopoderm Tts
  • Denmark · Scopoderm
  • Spain · Escopolamina B. Braun
  • Finland · Scopoderm
  • France · Bromhydrate De Scopolamine Renaudin, Scopoderm Tts
  • United Kingdom (Northern Ireland) · Hyoscine Hydrobromide Wockhardt Uk, Hyoscine Martindale Pharma
  • Ireland · Hyoscine Injection Bp Ethypharm, Kwells
  • Iceland · Scopoderm
  • Luxembourg · Scopoderm Tts
  • Malta · Kwells
  • Norway · Scopoderm
  • Sweden · Scopoderm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/98be7e90-7a5f-435d-889b-4bbd82350b4e
GET /v1/drugs/98be7e90-7a5f-435d-889b-4bbd82350b4e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Pleister voor transdermaal gebruik",
  "route": "Transdermaal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h09709_smpc.pdf",
  "strength": null,
  "atc_label": "Scopolamine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg09709",
  "excipients": [
    "COPOLYMEER VAN ETHYLEEN-VINYLACETAAT",
    "CROSPOVIDON (E 1202)",
    "ISOPROPYLPALMITAAT",
    "PARAFFINE, DUNVLOEIBAAR (E 905)",
    "POLYESTER",
    "POLYESTERFOLIE, BEKLEED MET POLYETHYLEEN EN ALUMINIUM",
    "POLYISOBUTEEN"
  ],
  "substances": [
    "HYOSCINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h09709.pdf",
  "authorised_at": "1982/11/22",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "09709",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about scopolamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console